Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Patient Resources
Clinical Trial Listings
What are Clinical Trials?
Become a Clinical Trial Volunteer
Useful Resources
FDA Approved Drugs
Professional Resources
Research Center Profiles
Market Research
Benchmark Reports
FDA Approved Drugs
Training Guides
Books
eLearning
Events
Newsletters
White Papers
SOPs
White Papers
Clinical Trial Listings
Advertise
Sign In
Create Account
Sign Out
My Account
Home
»
Topics
»
News
» Clinical Intelligence
Clinical Intelligence
RSS
Pharmos doses first patients in phase IIa gout trial
January 13, 2012
CenterWatch Staff
Lexicon’s LX411 enhances DPP-4 inhibitor in type 2 diabetics
January 13, 2012
CenterWatch Staff
Sinovac begins phase III trial in hand, foot and mouth disease
January 13, 2012
CenterWatch Staff
Giant leap for HIV cure
January 11, 2012
CenterWatch Staff
Morphotek to acquire samples from Fox Chase Cancer Center
January 11, 2012
CenterWatch Staff
Apogenix receives grant to commence phase II trial
January 9, 2012
CenterWatch Staff
Pfizer initiates phase I trial for Hemophilia drug
January 9, 2012
CenterWatch Staff
Circadian launches phase I cancer trial
January 9, 2012
CenterWatch Staff
Results of OncoGenex phase I/II Custirsen trial published
January 6, 2012
CenterWatch Staff
The CenterWatch Monthly, January 2012
January 3, 2012
CenterWatch Staff
Previous
1
2
…
118
119
120
121
122
123
124
125
126
…
166
167
Next
Upcoming Events
07
May
Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials
14
May
2024 Avoca Quality Consortium Summit
23
May
Maximizing Trial Success Requires Evolving Feasibility and Recruitment Strategies
21
Oct
MAGI@home Clinical Research Conference 2024
Featured Products
Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs
Best Practices for Clinical Trial Site Management
Featured Stories
Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials
Ask the Experts: Applying Quality by Design to Protocols
Clinical Trials Need Greater Representation of Obese Patients, Experts Say
FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More
Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials
The information you need to adapt your monitoring plan to changing times.
Learn More Here